Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CrO Biosciences announced Laura A. Jones as President. Jones will focus on leading global regulatory strategic development, oversight of regulatory operations, clinical operations and R&D systems implementation strategies.
read more
Repositive has announced IDMO will be joining its global network of CRO partners.
read more
Tuesday, October 17, 2023
P95 BV, a portfolio company of Ampersand Capital Partners and leading provider of clinical and observational services to vaccine developers, has signed an agreement to merge OnQ Research into P95.
read more
Thursday, October 21, 2021
PHASTAR, a global specialist biometrics contract research organization offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, announced today the appointment of Cary Morrill as Chief ...
read more
Croda announced all its excipient manufacturing sites globally are now EXCiPACT certified.
read more
Croda broke ground on 9 May 2023 on its newest manufacturing facility in Lamar, Clinton County, Pennsylvania.
read more
CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
read more
CROMSOURCE, an international contract research organization (CRO) providing services to the pharmaceutical, biotechnology, and medical device industries, has announced the appointment of four senior executives to its Management Team.
read more
Six CROs have introduced Align Clinical CRO, a new industry standards group dedicated to making it easier for sponsors and CROs to work together during clinical trials.
read more
Crown Bioscience, Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the ...
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Crown Bioscience announced the extension of its partnership with NEXT Oncology. This partnership will continue to leverage Crown Bioscience's experience in developing clinically relevant cancer organoid and patient-derived xenograft (PDX) models, ...
read more
Crown Bioscience announced four new preclinical translational NASH models in development.
read more
Crown Bioscience announced the opening of a new facility in San Diego, CA.
read more